SYMJEPI Epinephrine Injection Recalled for Defective Delivery System Nationwide
Adamis Pharmaceuticals is recalling 2,500 cartons of SYMJEPI (epinephrine injection) nationwide due to a defective delivery system that may clog the needle and prevent medication dispensing.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification mandates a minimum severity score of 4 (Severe). Although no illnesses or injuries have been reported in the source text, the potential failure of critical medication delivery creates serious risk to patients.
Plain-English summary
Adamis Pharmaceuticals Corporation is recalling 2,500 cartons of SYMJEPI (epinephrine injection, USP) 0.15 mg due to a defective delivery system. The product was distributed nationwide in the United States. The affected lot is lot # 21101Y, with expiration date 11/30/2022.
The defect involves potential clogging of the needle that could prevent the dispensing of epinephrine when the device is used. The FDA classified this as a Class I recall, indicating a serious potential health risk.
The recalled product
- Product
- SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.
- Manufacturer
- Adamis Pharmaceuticals Corporation
- Category
- Drug — Epinephrine Injection
- Hazard
- needle-clogging
- medication-delivery-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 21101Y
- Exp. 11/30/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27